>

PARABOLIC DRUGS (India) Valuation

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:4em;padding-top: 25px;;'>PA</div>
PARABOLIC DRUGS recent Real Value cannot be determined due to lack of data. The prevailing price of PARABOLIC DRUGS is 0.0. Based on Macroaxis valuation methodology, the entity cannot be evaluated at this time. This module determines value of PARABOLIC DRUGS from inspecting the entity fundamentals such as Operating Margin of (69.00) , Profit Margin of (78.66)  and Price to Sales of 0.08  as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point future time stocks prices and their ongoing real values will merge together.
Equity
Refresh

PARABOLIC Price Drivers Relationships

PARABOLIC DRUGS is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in beta category among related companies .
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Please check Your Equity Center. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Company logos by clearbit